Gross Profit On Sales Lave om Dato
Amarin USD 42.5M 14.47M 2023-09
Ardelyx USD 48.7M 29.85M 2023-09
Baxter International USD 1.49B 351M 2023-12
Bayer EUR 5.53B 796M 2023-09
BioCryst Pharmaceuticals USD 85.61M 4.06M 2023-09
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Insmed USD 65.25M 2.88M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
J&J USD 14.6B 374M 2023-12
Lexicon Pharmaceuticals USD 155K 154K 2023-09
Moderna USD 1.88B 2.29B 2023-12
Omeros USD 29.67M 1.19M 2021-09
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09
United Therapeutics USD 543.7M 4.4M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



United Therapeutics Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.